| Code |
| OMED |
| Title |
| PT Jayamas Medica Industri Tbk |
| Address |
|
| Background |
The Company is engaged in the business of manufacturing medical devices, electromedical medical devices, diagnostic tools, antiseptics and disinfectants, and other household health supplies. The Company’s main activities currently are manufacturing and distribution of medical devices. |
| Business cp product |
The Company is engaged in the business of manufacturing medical devices, electromedical medical devices, diagnostic tools, antiseptics and disinfectants, and other household health supplies. The Company’s main activities currently are manufacturing and distribution of medical devices. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Yacobus Jemmy Hartanto | | | Commissioner | : Siane Soetanto | | | Independent Commissioner | : Dr. Supriyantoro | | | | | | Per 31 Mar 2023 | | |
|
| Directors |
| President Director | : Dra. Herlien Sri Ariani, APT | | | Director | : Leonard Hariadi Hartanto | | | Director | : Louis Krisnadi Hartanto | | | Director | : Eka Suwignyoo | | | | | | Per 31 Mar 2023 | | |
|
| Underwriter |
| PT. CLSA Sekuritas Indonesia | | | PT. CIMB Niaga Sekuritas | | | PT. Ciptadana Sekuritas Asia | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT Intisumber Hasilsempurna | 22540000000 | 83.3 | | | | Yacobus Jemmy Hartanto | 230000000 | 0.85 | | | | Siane Soetanto | 230000000 | 0.85 | | | | Public | 4058850000 | 15 | | | | | | | | | As of Mar 31, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 20408-Nov-202225405885000027058850000
|
| Other infos |
|
| Created date |
| 2023-08-30 11:35:17 |
| Revised date |
| 2023-08-30 11:35:17 |
| Finance |
| PT Jayamas Medica Industri Tbk |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|